biobiz.blogspot.com
Bio Business: June 2015
http://biobiz.blogspot.com/2015_06_01_archive.html
Commentary on the business of drug discovery and other life science industries. Friday, June 12, 2015. Accelerating life science startups. On Thursday, I attended the Indie Bio SF. Demo Day, a coming out party for 12 companies in its San Francisco accelerator. The sponsor of Indie Bio (which has a second site in Cork, Ireland. Believes this is one of the first life science accelerators. As with a life science incubator, the accelerator. Raghu Machiraju, CEO): lower cost, higher reliability lab automation.
synbiobeta.com
The Automation War: Cloud Labs vs. Desktop Robots - SynBioBeta
https://synbiobeta.com/the-automation-war-cloud-labs-vs-desktop-robots
Director of Synthetic Biology Future Science Platform, will be speaking at #SB7Conf. Sponsorship & Exhibition. People of The Industry. BioPharma & Healthcare. Chemicals, Energy & Environment. Consumer Products & Manufacturing. Cloud Laboratories / Automation. Startup Incubators and Accelerators. The Automation War: Cloud Labs vs. Desktop Robots. June 5, 2015. The Automation War: Cloud Labs vs. Desktop Robots. Max Hodak, CEO of Transcriptic, speaking at SynBioBeta London 2015. What would be ideal is if th...
biobiz.blogspot.com
Bio Business: Accelerating life science startups
http://biobiz.blogspot.com/2015/06/accelerating-life-science-startups.html
Commentary on the business of drug discovery and other life science industries. Friday, June 12, 2015. Accelerating life science startups. On Thursday, I attended the Indie Bio SF. Demo Day, a coming out party for 12 companies in its San Francisco accelerator. The sponsor of Indie Bio (which has a second site in Cork, Ireland. Believes this is one of the first life science accelerators. As with a life science incubator, the accelerator. Raghu Machiraju, CEO): lower cost, higher reliability lab automation.
ryanbethencourt.com
About — RB
http://www.ryanbethencourt.com/about
Working to accelerate innovations in biotechnology and medicine through collaborative R&D, biohacking and open innovation. He has had extensive experience with clinical development from IND through to FDA approval, biotech fundraising and biotech business development. Ryan prides himself on disrupting the current status quo in both medical and consumer biotech. He was previously the Life Sciences head at the XPRIZE Foundation, the co-founder and CEO of Berkeley Biolabs. And the co-founder of Sudo Room.